Signature Genomic Laboratories, LLC Detects Chromosome Abnormalities in Individuals with Genetic Disorders Associated with Susceptibility to Cancer
SPOKANE, Wash.--(BUSINESS WIRE)--Geneticists at Signature Genomic Laboratories recently demonstrated that microarray-based genetic testing can identify chromosome abnormalities that cause genetic disorders associated with susceptibility to cancer prior to the onset of symptoms.